Hypomethylating Agents (HMAs)
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Hypomethylating Agents (HMAs)
Jan 5, 2024, 17:36 |
Insight
Talha Badar: What is the right duration of Venetoclax with HMA for AML?
Talha Badar, Assistant Professor of Oncology at Mayo Clinic Comprehensive Cancer Center, shared on X/Twitter:…
Dec 24, 2023, 18:42 |
Insight
Naveen Pemmaraju: Important new paper led by Alex Bataller and Tapan Kadia
Naveen Pemmaraju shared on X/Twitter: "Important New paper just out in Blood Advances led by…
Nov 20, 2023, 04:08 |
Insight
Adam C Palmer: You don’t need ‘1+1 makes 3’ if you can have ‘5+5 makes 10’
David Steensma, Chief Medical Officer at Ajax Therapeutics, and Anthony Letai, Professor at Dana-Farber Cancer…
All:
3
Posts:
1 - 100
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Gavin Creel: Broadway Icon Dies After Battle with Rare Sarcoma at 48
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube